ÂÜÀòÂÒÂ×

David Brautigan is the F. Palmer Weber endowed chair for medical research and Director of the Center for Cell Signaling in the Department of Microbiology, Immunology and Cancer Biology at the University of Virginia School of Medicine. He is the co-leader of the Cancer Cell Signaling program, and member of the executive committee of the UVA Cancer Center. His research has focused on cell signaling and protein phosphorylation, and the biochemistry of phosphatase and kinase enzymes. Dr. Brautigan has authored more than 240 scientific articles, and been principal investigator of research grants from the National Institutes of Health (NIH) and various private foundations. He was elected fellow of the American Association for the Advancement of Science and serves on the editorial board for scientific journals, an advisor for programs and centers at Virginia and other Universities, and on scientific advisory boards for foundations. He was one a founding member of the Molecular and Integrative Signal Transduction (MIST) study section at NIH and its chairman 2010-2012. He has more than 30 years experience as a consultant for pharmaceutical and biotechnology companies, and has supported commercial distribution of over a dozen licensed research reagents.

David Brautigan received his B.A. degree with honors in chemistry at Kalamazoo College, MI, a M.S. in chemistry and a Ph.D. in biochemistry from Northwestern University in Evanston, Illinois. He was a Muscular Dystrophy Association postdoctoral fellow at the University of Washington, Seattle with 1992 Nobel laureate Edmond H. Fischer. Before being recruited to Virginia in 1994 Dr. Brautigan was Professor of Medical Science at Brown University, Providence, RI where he taught biochemistry to undergraduate and medical students and served as Director of the Ph.D. program in Molecular, Cell Biology and Biochemistry.